Charles K. Gayer serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Charles K. Gayer has executed 14 insider transactions totaling $230.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 22, 2025 involved exercising options for 10,091 shares valued at $50.9K.
Charles K. Gayer currently holds 902,583 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles K. Gayer has been a net buyer of BCRX stock. They have purchased $164.1K and sold $66.5K worth of shares.
Charles K. Gayer's most recent insider trade was on Dec 22, 2025, when they sold 10,091 shares at $5.04 per share.
Get notified when new Form 4 filings are submitted
| 14,142 |
| $3.22 |
| Discretionary |
| Dec 22, 2025 | BCRX | $275.5K | Option Exercise | 50,000 | $5.51 | Discretionary |
| Dec 19, 2025 | BCRX | $85.0K | Payment | 11,477 | $7.41 | Discretionary |
| Dec 17, 2025 | BCRX | $0 | Award | 471,000 | $N/A | Discretionary |
| Dec 12, 2025 | BCRX | $61.9K | Payment | 8,181 | $7.57 | Discretionary |
| May 13, 2024 | BCRX | $164.1K | Purchase | 30,000 | $5.47 | Discretionary |
| Dec 19, 2023 | BCRX | $15.0K | Payment | 2,482 | $6.05 | Discretionary |
| Dec 14, 2023 | BCRX | $37.6K | Payment | 5,840 | $6.43 | Discretionary |
| Dec 14, 2023 | BCRX | $0 | Award | 34,000 | $N/A | Discretionary |
| Dec 19, 2022 | BCRX | $0 | Award | 34,000 | $N/A | Discretionary |
| Dec 15, 2022 | BCRX | $66.5K | Sale | 6,100 | $10.90 | Discretionary |
| Dec 14, 2021 | BCRX | $0 | Award | 80,000 | $N/A | Discretionary |
| Dec 14, 2021 | BCRX | $0 | Award | 125,000 | $N/A | Discretionary |